Allworth Financial’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.85K | Sell |
275
-28
| -9% | -$392 | ﹤0.01% | 3399 |
|
|
2025
Q1 | $4.69K | Buy |
303
+293
| +2,930% | +$4.54K | ﹤0.01% | 2784 |
|
|
2024
Q4 | $234 | Buy |
+10
| New | +$234 | ﹤0.01% | 3750 |
|
|
2024
Q3 | – | Sell |
-64
| Closed | -$1.37K | – | 3767 |
|
|
2024
Q2 | $1.37K | Sell |
64
-22
| -26% | -$472 | ﹤0.01% | 3058 |
|
|
2024
Q1 | $1.77K | Sell |
86
-803
| -90% | -$16.5K | ﹤0.01% | 2852 |
|
|
2023
Q4 | $19.1K | Buy |
889
+840
| +1,714% | +$18K | ﹤0.01% | 1679 |
|
|
2023
Q3 | $1.01K | Buy |
+49
| New | +$1.01K | ﹤0.01% | 2846 |
|
|
2023
Q2 | – | Sell |
-8
| Closed | -$185 | – | 3287 |
|
|
2023
Q1 | $185 | Hold |
8
| – | – | ﹤0.01% | 3023 |
|
|
2022
Q4 | $222 | Hold |
8
| – | – | ﹤0.01% | 2767 |
|
|
2022
Q3 | $0 | Hold |
8
| – | – | ﹤0.01% | 2753 |
|
|
2022
Q2 | $0 | Buy |
+8
| New | – | ﹤0.01% | 2486 |
|